Relay Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights on February 26, 2025

Rhea-AI Summary

Relay Therapeutics (NASDAQ: RLAY), a clinical-stage precision medicine company, announced it will release its fourth quarter and full year 2024 financial results and corporate highlights on Wednesday, February 26, 2025, after U.S. market close. The company specializes in combining computational and experimental technologies for drug discovery.

News Market Reaction

-1.68%

1 alert

-1.68% News Effect

On the day this news was published, RLAY declined 1.68%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

CAMBRIDGE, Mass., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, will report fourth quarter and full year 2024 financial results and corporate highlights after the U.S. financial markets close on Wednesday, February 26, 2025.

About Relay Therapeutics

Relay Therapeutics (Nasdaq: RLAY) is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. As the first of a new breed of biotech created at the intersection of complementary techniques and technologies, Relay Therapeutics aims to push the boundaries of what’s possible in drug discovery. Its Dynamo^® platform integrates an array of leading-edge computational and experimental approaches designed to drug protein targets that have previously been intractable or inadequately addressed. Relay Therapeutics’ initial focus is on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. For more information, please visit www.relaytx.com or follow us on Twitter.

Contact:
Pete Rahmer
prahmer@relaytx.com

Media:
Dan Budwick
1AB
973-271-6085
dan@1abmedia.com

FAQ

When will Relay Therapeutics (RLAY) release Q4 2024 earnings?

Relay Therapeutics will release its Q4 and full year 2024 financial results on Wednesday, February 26, 2025, after U.S. market close.

What period will Relay Therapeutics' (RLAY) upcoming earnings report cover?

The upcoming earnings report will cover both the fourth quarter and full year 2024 financial results.

Will Relay Therapeutics (RLAY) include corporate highlights in their Q4 2024 report?

Yes, Relay Therapeutics will include corporate highlights along with their Q4 and full year 2024 financial results.

What time will RLAY release their Q4 2024 earnings report?

Relay Therapeutics will release their earnings report after the U.S. financial markets close on February 26, 2025.